Antheia CEO Joins Fierce JPM Week as Panelist Speaker on Onshoring Pharmaceutical Supply Chains

Antheia CEO Joins Fierce JPM Week as Panelist Speaker on Onshoring Pharmaceutical Supply Chains

MENLO PARK, Calif., Jan. 8, 2026 /PRNewswire/ -- Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced that CEO and co-founder, Dr. Christina Smolke will join Fierce JPM Week as a featured panelist. Dr. Smolke will…

JPM to bring more deals and happy CEOs

STAT reporters preview the upcoming JP Morgan Conference and the biotech trends to watch this year.

mRNA drug developer Arcturus to share its work at major health conference

Arcturus CEO Joseph Payne will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Jan. 12, 2026, at 5:15 p.m. PT.

FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference

PORTO, Portugal--(BUSINESS WIRE)--FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 – 15, 2026 in San Francisco, CA. With more than a decade of expertise, FJBio has supported over [...] The post FairJourney Bio to present at J.P. Morgan 2026 Healthcare Confe…

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference Melbourne (Australia) and Indianapolis (United States) | 8 January 2026 Telix today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA (U.S.).  Telix will host a presentation on Monday, 12 January at 9:00 am PST (12:00 pm E…